Chlamydia trachomatis (C. trachomatis) is the most common bacterial sexually transmitted infection (STI). Although most genital C. trachomatis infections remain asymptomatic but infection with these bacteria is the leading cause of complications, such as pelvic inflammatory disease (PID), tubal factor infertility and abortion. Objectives: The objective of this study was to estimate the frequency of C. trachomatis infection among symptomatic and asymptomatic women, by a polymerase chain reaction (PCR) based assay. Patients and Methods: This was a cross-sectional study conducted over the period from May 2012 to February 2013. A total of 240 nonduplicate endocervical samples were taken from married women; endocervical swabs were collected from women referred to Qazvin Kowsar Gynecology Hospital by a training midwife. The specimens were tested for C. trachomatis by a PCR-based assay for the pha gene. Results: Out of the 240 female participants, 184 (76.7%) were symptomatic and 56 (23.3%) were asymptomatic cases. The mean age of cases was 37.1 ± 0.9 years. Twenty (8.3%) of the 240 samples were diagnosed as Chlamydia positive according to PCR results. The prevalence of asymptomatic C. trachomatis infections was six (10.7%), while there were 14 (7.6%) in symptomatic cases. Although positive PCR results have shown in women with vaginosis (7.1%), abortion (5.1%), premature birth and low birth weight below 2.5 kg (7.7%) but the chi-square test did not indicate a significant relationship between positive PCR test results and these symptoms.
Background
Chlamydia trachomatis (C. trachomatis) is an obligate intra-cellular pathogen and the most frequent sexually transmitted bacterium worldwide (1) (2) (3) (4) . Most infections occur without symptoms and asymptomatic manifestation of urogenital chlamydial infection can be observed in ~30% of patients. Although effective antimicrobial therapy is available for C. trachomatis, yet undetected and untreated infections lead to diseases such as salpingitis, pelvic inflammatory disease (PID), tubal infertility and abortion (5) (6) (7) (8) (9) . Chlamydia trachomatis in the cervix could be transmitted to a neonate during passage through an infected birth canal, resulting in neonatal pneumonia (6, 10) .
The gold standard for diagnosis of C. trachomatis infection has traditionally been a culture of swab from the endocervix in women or the urethra in men (6) . However, the methodological challenges of culturing of this organism and difficulty of this method have led to the development of non-culture-based tests, including antigen-detection tests and nucleic acid hybridization. These techniques however, fail to detect a substantial proportion of infections. Newer tests are accordingly required to be developed that could amplify and detect C. trachomatis-specific DNA or RNA sequences, with greater sensitivity than first generation non-culture-based tests (10) (11) (12) (13) (14) . In many studies, the target gene for nucleic acid amplification tests (NAATs) has been the cryptic plasmid. Some studies give evidence or suggest that plasmid-free variants are present in clinical samples. Thus, infections caused by plasmidfree variants will be undetected if the plasmid is used as the target gene (12) . Targets for amplification have included both cryptic plasmid (7, 8, 10, 18, 19, 22 -24, 27 ) and chromosomal genes, including those for the major outer membrane protein (MOMP) (2, 11, 23, 25, 33) , gyrA and phospholipase D endonuclease superfamily gene (PRPHA).
Objectives
The objective of this study was to estimate the frequency of C. trachomatis infection among symptomatic and asymptomatic women, by a polymerase chain reaction (PCR)-based assay using unique sequences (15).
Patients and Methods
This was a cross-sectional study conducted over the period from May 2012 to February 2013. During a ten-monthperiod, 240 endocervical samples were taken from married women, who had referred to Kowsar Gynecology Hospital Qazvin, by a training midwife. The patient's demographic data and medical histories were collected by direct interviews and completion of the questionnaire.
Sample Collection
Briefly, cervical mucus was removed prior to insertion of a Dacron swab into the endocervical canal; the swab was then immersed in 1 mL of phosphate buffered saline (PBS) transport medium. All PBS media were maintained at 4ºC during specimen collection and then aliquoted into DNase and RNase free microtubes and frozen at -80ºC within four hours of collection until DNA extraction (16).
DNA Extraction
DNA was extracted from endocervical samples using the boiling technique by DNG PLUS (CinnaGen, Iran). The concentration of DNA samples was determined as micrograms per milliliter based on A260 values and adjusted to 1 µL/mL prior to PCR amplification. All extracted DNA were stored at -20ºC until analysis by PCR.
Detection of Chlamydia trachomatis by PCR
PCR assay was performed for detection of C. trachomatis by the pha gene. The primers were F-(5'TCTTTTTAAACCTC CGGAACCCACTT3') and R-(5'GGATGGCATCGCATAGCATTCT TTG3'). The PCR product size was 378 bp. PCR amplification was performed in a final volume of 20 µL, containing 1 µL of each primer (10 pmol/µL, 10 µL master mix sybr green (Bioneer-USA)), 6 µL of distilled water and 2 µL of DNA samples. Sequenced C. trachomatis DNA was used as the positive control and distilled water was used as the negative control. DNA amplification was carried out with the following thermal cycling profile for pha gene; 10 minutes of initial denaturation at 95ºC followed by 35 cycles of amplification. Each cycle consisted of denaturation at 95ºC for 15 seconds, annealing at 60ºC for 30 seconds, and extension at 72ºC for 30 seconds. The PCR products were analyzed by 1.5% agarose gel electrophoresis and the product size was estimated using a 100 bp DNA ladder (Fermentas).
Statistical Analyses
Data Statistical analysis was performed using the Statistical Package for the Social Sciences software (SPSS) (version 19.0; SPSS Inc, Chicago, IL, USA). Data were summarized by frequencies and percentages for categorical variables and by means and standard deviations for normally distributed data. The relationship between results was analyzed by chi-square tests. A P value of < 0.05 was considered as statistically significant.
Results
The study population consisted of 240 married women; 184 (76.7%) symptomatic and 56 (23.3%) asymptomatic cases. The mean age of cases was 37.1 ± 0.9 years. During the period of this study, 240 married women with various complications were enrolled, including: 18 (7.5%) infertility, 58 (24.16%) abortion, 126 (52.5%) vaginosis (signs and symptoms included vaginal discharge, vaginal irritation and dysuria), 13 (5.4%) premature birth, 15 (6.25%) and low birth weight below 2.5 kg. Out of the 240 endocervical swab samples, 20 (8.3%) were positive for C. trachomatis by PCR of pha gene (Figure 1 ). Of the 56 asymptomatic women, six (10.7%) had chlamydia infection while among the 184 symptomatic cases 14 (7.6%) had this infection, according to the PCR results. Among symptomatic women with chlamydial infection, infertility was not present in any of the cases (0%), while abortion was present in three (5.1%), vaginosis in nine (7.1%) premature birth in one (7.7%) and low birth weight in one (7.7%).
The chi-square test was used to evaluate the relationship between symptoms of genital infection using PCR. None of the symptoms such as genital discharge, dysuria, genital itching (vaginosis), abortion, premature birth, low birth weight (below 2.5 kg) and infertility showed a significant association with the infection (Table 1 ). 
Discussion
Urogenital C. trachomatis infection has become a major public health problem world-wide and is one of the most frequent causes of sexually transmitted diseases (1, 2) . It is a common cause of urethritis and cervicitis. Some reported sequelae include PID, abortion, tubal factor infertility, epididymitis, proctitis and reactive arthritis (5-9). The majority of chlamydia-infected individuals are asymptomatic, and remain unnoticed and untreated. Infected women may be at risk of gynaecological complications (e.g. PID and tubal infertility), and determine the reservoir for onward transmission in the population (17) .
In the current study, the prevalence of C. trachomatis infection among 240 women attending Kowsar Gynecology Hospital in Qazvin was 8.3%; six cases were asymptomatic (10.7%), while 14 (7.6%) were symptomatic. The chi-square test did not show a significant relationship between positive test results and vaginosis, abortion, premature birth, low birth weight below 2.5 kg and infertility.
Torrone et al. (18) reported that the prevalence of C. trachomatis genital infection among people aged 14- (9) reported the prevalence of C. trachomatis infection among 377 (37.9% Qataris and 62.1% non-Qataris) healthy women attending primary healthcare centers in Qatar. The specimens were tested for C. trachomatis by a PCRbased assay. Prevalence of C. trachomatis infection was 5.3% among Qatari women and 5.5% among non-Qatari women. Similar to our study, this high prevalence may reflect, in part, the limited access to and use of chlamydia screening and management (9). Araujo et al. (20) in central Brazil reported that the overall prevalence of C. trachomatis infection by PCR was 19.6%. Cuffini et al. (21) reported that the prevalence of genital C. trachomatis infection in asymptomatic women in Argentine was 13.7%. Their results showed higher prevalence of C. trachomatis infection among Latin-American women than our study.
The present study showed that C. trachomatis endocervical infection could be present in symptomatic (7.6%) as well as asymptomatic women (10.7%). The majority of chlamydia-infected individuals were asymptomatic, and remained undetected, unnoticed and untreated. Infected women may be at risk of gynecological complications (e.g. PID and tubal infertility), and determine the reservoir for onward transmission in the population. Strategies for the control of infection and prevention of its complications are only partially effective because there is no available vaccine while there is high-risk sexual behavior in the population. Screening programs have been introduced as an additional strategy for early detection and treatment of infected cases. Cost-effectiveness of screening is largely determined by the rates of complications prevented. Nucleic acid amplification methods, such as PCR, have high sensitivity, specificity and require a short duration of time for obtaining results, therefore are preferred for diagnosis of chlamydial infection.
